[Carpipramine in neuroses].
Having outlined the limits of drug-therapy in neuroses, where it may support psychotherapy, a treatment the use of which is still questioned by some, the authors review the rare publications involving the indications of Carpipramine in neurotic syndroms. Active upon symptom patterns consisting essentially of asthenia, inhibition and psychomotor impairment, raising the level of activity, stimulating enthusiasm and relational activity, Carpipramine would appear to represent a new advance in the treatment of some neurotic syndroms, partially encompassing the border-line indications of anti-depressants and those of certain disinhibitory neuroleptic agents.
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D002986:Clinical Trials as Topic; D003984:Dibenzazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007046:Hysteria / Q000188:drug therapy; D008297:Male; D009440:Neurasthenia / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010698:Phobic Disorders / Q000188:drug therapy
D003984:Dibenzazepines
La carpipramine dans les névroses.